1. Home
  2. IOVA vs CRI Comparison

IOVA vs CRI Comparison

Compare IOVA & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$14.29

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$31.16

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
CRI
Founded
2007
1865
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2008
2002

Fundamental Metrics

Financial Performance
Metric
IOVA
CRI
Price
$14.29
$31.16
Analyst Decision
Buy
Hold
Analyst Count
10
6
Target Price
$9.00
★ $35.60
AVG Volume (30 Days)
★ 11.4M
1.5M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
★ 2.74%
EPS Growth
★ 14.84
N/A
EPS
N/A
★ 3.26
Revenue
N/A
★ $2,898,426,000.00
Revenue This Year
$47.74
$4.57
Revenue Next Year
$40.31
$1.12
P/E Ratio
★ N/A
$9.51
Revenue Growth
N/A
★ 1.91
52 Week Low
$1.76
$27.15
52 Week High
$11.17
$44.44

Technical Indicators

Market Signals
Indicator
IOVA
CRI
Relative Strength Index (RSI) 85.96 43.83
Support Level $3.57 $28.86
Resistance Level N/A $32.07
Average True Range (ATR) 0.67 1.21
MACD 0.27 0.37
Stochastic Oscillator 99.84 71.65

Price Performance

Historical Comparison
IOVA
CRI

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: